Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive lacosamide for uncontrolled primary generalized tonic-clonic seizures in idiopathic generalized epilepsy
2011-003100-21Phase 3Completed
- Sponsor
- UCB
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in idiopathic epilepsy (IGE) comparing Lacosamide adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Time to the second primary generalized tonic-clonic seizure. Started Apr 2015; status: completed.
02
Drugs
lacosamide
03
Conditions
idiopathic epilepsy (IGE)
Beyond the preview
Go deeper on 2011-003100-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003100-21.